Black Diamond Therapeutics, Inc. Quarterly Debt-to-equity in % from Q3 2020 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Black Diamond Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q3 2020 to Q3 2024.
  • Black Diamond Therapeutics, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 37.2 %, a 4.12% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 37.2 +1.47 +4.12% Sep 30, 2024
Q2 2024 33.7 -4.21 -11.1% Jun 30, 2024
Q1 2024 35.6 +1.25 +3.64% Mar 31, 2024
Q4 2023 35.9 +4.36 +13.8% Dec 31, 2023
Q3 2023 35.7 +6.3 +21.4% Sep 30, 2023
Q2 2023 37.9 +10.8 +40% Jun 30, 2023
Q1 2023 34.4 +11.6 +51% Mar 31, 2023
Q4 2022 31.6 +12.9 +69.5% Dec 31, 2022
Q3 2022 29.4 +15.6 +113% Sep 30, 2022
Q2 2022 27.1 +17.6 +186% Jun 30, 2022
Q1 2022 22.8 +16.4 +259% Mar 31, 2022
Q4 2021 18.6 +14.5 +353% Dec 31, 2021
Q3 2021 13.8 +9.97 +258% Sep 30, 2021
Q2 2021 9.46 Jun 30, 2021
Q1 2021 6.34 Mar 31, 2021
Q4 2020 4.11 Dec 31, 2020
Q3 2020 3.87 Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.